Golden Meditech Stem Cells (BVI) Co Ltd 13D and 13G filings for Global Cord Blood Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-05-31 06:14 am Unchanged | 2022-05-27 | 13D | Global Cord Blood Corporation CORBF | Golden Meditech Stem Cells (BVI) Co Ltd | 78,874,106 64.900% | 0 (Unchanged) | Filing |
| 2022-05-23 06:30 am Purchase | 2022-05-23 | 13D | Global Cord Blood Corporation CORBF | Golden Meditech Stem Cells (BVI) Co Ltd | 78,874,106 64.900% | 78,874,106 (New Position) | Filing |